Neuroone Medical Technologies (NMTC) FCF Margin (2011 - 2026)
Neuroone Medical Technologies (NMTC) reported FCF Margin of 73.43% for Q1 2026, down 6915.0% year-over-year from 1.08% in Q1 2025, and up 32.71% sequentially from 109.13% in Q4 2025.
Neuroone Medical Technologies (NMTC) FCF Margin (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies has disclosed FCF Margin across 12 years of filings, most recently posting 73.43% for Q1 2026.
- Quarterly FCF Margin fell 6915.0% year-over-year to 73.43% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 82.33% (up 371.0% YoY) and the FY2025 annual result came in at 32.09%, up 29030.0% from the prior year.
- FCF Margin rose to 73.43% in Q1 2026, from 109.13% in the prior quarter.
- Across five years, FCF Margin topped out at 1383.43% in Q3 2022 and bottomed at 9061.09% in Q1 2022.
- The 5-year median for FCF Margin is 287.63% (2024), against an average of 1351.74%.
- Year-over-year, FCF Margin tumbled 261163 bps in 2022 and soared 826156 bps in 2023.
- Neuroone Medical Technologies' FCF Margin stood at 3057.95% in 2022, then soared by 87 bps to 393.45% in 2023, then soared by 101 bps to 5.61% in 2024, then plunged by 2046 bps to 109.13% in 2025, then jumped by 33 bps to 73.43% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 73.43%, 109.13%, and 56.05% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.44% |
| 10 | Neuroone Medical Technologies | 26.73 Mn | 23.93 Mn | 990,264.00 | -73.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.43% |
| Dec 31, 2025 | -109.13% |
| Sep 30, 2025 | -56.05% |
| Jun 30, 2025 | -88.86% |
| Mar 31, 2025 | -4.28% |
| Dec 31, 2024 | 5.61% |
| Sep 30, 2024 | -993.00% |
| Jun 30, 2024 | -287.63% |
| Mar 31, 2024 | -160.21% |
| Dec 31, 2023 | -393.45% |
| Sep 30, 2023 | -399.10% |
| Jun 30, 2023 | -488.89% |
| Mar 31, 2023 | -799.53% |
| Dec 31, 2022 | -3,057.95% |
| Sep 30, 2022 | 1,383.43% |
| Jun 30, 2022 | -8,396.07% |
| Mar 31, 2022 | -9,061.09% |
| Dec 31, 2021 | -8,120.86% |
| Sep 30, 2021 | -4,270.97% |
| Jun 30, 2021 | -5,784.44% |